The effect of dapagliflozin ointment on induced psoriasis in an experimental model

Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treat...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicine and life Vol. 17; no. 3; pp. 281 - 285
Main Authors Al Bahadly, Waleed Khaled Younis, Bdioui, Ahlem, Al-Gazally, Moaed, Al-Saedi, Haider, Salah, Sihem Hmissa Belhaj, Ramadhan, Mukhallad
Format Journal Article
LanguageEnglish
Published Romania Carol Daila University Foundation 01.03.2024
Carol Davila University Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment.
AbstractList Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment.
Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment.Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment.
Author Bdioui, Ahlem
Al-Gazally, Moaed
Al-Saedi, Haider
Ramadhan, Mukhallad
Salah, Sihem Hmissa Belhaj
Al Bahadly, Waleed Khaled Younis
Author_xml – sequence: 1
  givenname: Waleed Khaled Younis
  surname: Al Bahadly
  fullname: Al Bahadly, Waleed Khaled Younis
  organization: Department of Physiology, Faculty of Medicine Ibn Al Jazzar, University of Sousse, Sousse, Tunisia
– sequence: 2
  givenname: Ahlem
  surname: Bdioui
  fullname: Bdioui, Ahlem
  organization: Department of Physiology, Faculty of Medicine Ibn Al Jazzar, University of Sousse, Sousse, Tunisia
– sequence: 3
  givenname: Moaed
  surname: Al-Gazally
  fullname: Al-Gazally, Moaed
  organization: Department of Clinical Biochemistry, College of Medicine, University of Al-Ameed, Karbala, Iraq
– sequence: 4
  givenname: Haider
  surname: Al-Saedi
  fullname: Al-Saedi, Haider
  organization: Department of Pharmacology, College of Pharmacy, University of Al-Ameed, Karbala, Iraq
– sequence: 5
  givenname: Sihem Hmissa Belhaj
  surname: Salah
  fullname: Salah, Sihem Hmissa Belhaj
  organization: Department of Physiology, Faculty of Medicine Ibn Al Jazzar, University of Sousse, Sousse, Tunisia
– sequence: 6
  givenname: Mukhallad
  surname: Ramadhan
  fullname: Ramadhan, Mukhallad
  organization: Department of Pathology, College of Medicine, University of Misan, Misan, Iraq
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39044933$$D View this record in MEDLINE/PubMed
BookMark eNpdkM1LAzEQxYNUbK1ePUrAi5fVfO52TyLiFwiCKHhb0mRiU7LJuumK-tcbsYo6lxlmHo_fvG00CjEAQnuUHDFJGTtetr5ghPGCkJnYQBM6E6LglFaj9ZxFj2O0m9KS5BKyLEu-hca8JkLUnE_Q3f0CMFgLeoWjxUZ16sk76-O7Czi6sGoh5EvALphBg8Fdir1TyaW8wSpgeO2gd58q5XEbDfgdtGmVT7C77lP0cHF-f3ZV3NxeXp-d3hQdFYQVlApeGyAMhLUzPS-1KLm0umSEWpVJLTGV4nU117Sq5zXIijEuDUjDBaeaT9HJl283zFswOiP0yjddplH9WxOVa_5egls0T_GloZSVrMyxTdHh2qGPzwOkVdO6pMF7FSAOqeE5VcJqmkObooN_0mUc-pD_azglUlLJqk_D_d9IPyzfefMPNUyE3A
ContentType Journal Article
Copyright 2024 by the authors.
Copyright Carol Daila University Foundation Mar 2024
2024 by the authors. 2024
Copyright_xml – notice: 2024 by the authors.
– notice: Copyright Carol Daila University Foundation Mar 2024
– notice: 2024 by the authors. 2024
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BYOGL
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.25122/jml-2023-0084
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
East Europe, Central Europe Database
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
East Europe, Central Europe Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BYOGL
  name: East Europe, Central Europe Database
  url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/eastcentraleurope
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1844-3117
EndPage 285
ExternalDocumentID 39044933
Genre Journal Article
GroupedDBID ---
3V.
53G
7X7
88E
8FE
8FH
8FI
8FJ
8R4
8R5
ABDBF
ABUWG
ACPRK
ADBBV
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
BYOGL
CCPQU
CGR
CUY
CVF
DIK
EBD
ECM
EIF
EMOBN
EOJEC
ESX
F5P
FYUFA
HCIFZ
HMCUK
HYE
KQ8
LK8
M1P
M7P
MK0
NPM
O5R
O5S
OBODZ
OK1
PGMZT
PQQKQ
PROAC
PSQYO
Q2X
RPM
SV3
TR2
TUS
UKHRP
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-p1402-11439de02e4ff8cb6c4635fc6201fa566f0d7a397bc179b9e572235de5d3431c3
IEDL.DBID RPM
ISSN 1844-122X
1844-3117
IngestDate Tue Sep 17 21:27:53 EDT 2024
Sat Oct 26 04:34:19 EDT 2024
Thu Oct 10 20:47:45 EDT 2024
Sat Nov 02 12:21:45 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Keywords mice
dapagliflozin
psoriasis
imiquimod
Language English
License 2024 by the authors.
This open access article is published and licensed by the Journal of Medicine and Life under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p1402-11439de02e4ff8cb6c4635fc6201fa566f0d7a397bc179b9e572235de5d3431c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262602/
PMID 39044933
PQID 3105515272
PQPubID 136187
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11262602
proquest_miscellaneous_3084029166
proquest_journals_3105515272
pubmed_primary_39044933
PublicationCentury 2000
PublicationDate 2024-Mar
20240301
PublicationDateYYYYMMDD 2024-03-01
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-Mar
PublicationDecade 2020
PublicationPlace Romania
PublicationPlace_xml – name: Romania
– name: Bucharest
PublicationTitle Journal of medicine and life
PublicationTitleAlternate J Med Life
PublicationYear 2024
Publisher Carol Daila University Foundation
Carol Davila University Press
Publisher_xml – name: Carol Daila University Foundation
– name: Carol Davila University Press
SSID ssj0000456663
Score 2.3386645
Snippet Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules....
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 281
SubjectTerms Albinism
Animals
Benzhydryl Compounds - pharmacology
Biomarkers
Cytokines
Cytokines - metabolism
Diabetes
Disease Models, Animal
Erythema
Glucose
Glucosides - administration & dosage
Glucosides - pharmacology
Glucosides - therapeutic use
Imiquimod
Inflammation
Keratin
Male
Mice
Ointments
Original
Psoriasis
Psoriasis - chemically induced
Psoriasis - drug therapy
Psoriasis - pathology
Tumor necrosis factor-TNF
Variance analysis
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFA46QbyIv61OieA1LCZtup5ExCHCPIiD3kbSJFqZabXbxb_el7abm4LXNpT2vTTvey8v34fQpc5sYpWmhOpY-9JNSCTjihiI1RJirFLaHxQePor7UfiQRmlbcKvatsr5mlgv1LrIfI28x72So9dgZdflB_GqUX53tZXQWEcbV4wK39IVp_GixuLhiqjF1CCP8fR8LG14G31QZ7239wnx6uGE1uSmfxHm70bJpcgz2EHbLWTEN42Pd9GacXtoc9huiu-jJ3A1bvoycGGxhvD3MsntpPjKHS5yV_eR48JhSL_BkRqXFXyYrPIKrmDp8DLLP66lcQ7QaHD3fHtPWqkEUkKGxAhkNTzRhjITWtvPlMhCQBI2ExDfrQQrWPCFBOyhMvgDVWKiGHBBpE2kOUCIjB-ijiucOUY45kLLiBkBjwkTRSWVpg8DhYJlnSsToO7cUON2vlfjH-8E6GJxG2aq336QzhQzGANWpgzgqAjQUWPXcdlQaox5QsMw4TxA_RWLLwZ4FuzVOy5_rdmw_RkoSMrYyf_vdYq2wNdh0z7WRZ3p58ycAZ6YqvN60nwDZY3L6w
  priority: 102
  providerName: ProQuest
Title The effect of dapagliflozin ointment on induced psoriasis in an experimental model
URI https://www.ncbi.nlm.nih.gov/pubmed/39044933
https://www.proquest.com/docview/3105515272
https://www.proquest.com/docview/3084029166
https://pubmed.ncbi.nlm.nih.gov/PMC11262602
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT-MwEB3xIaG9IL52t1AqI3ENjezEbY5QgRBSEUIg9VbZsc0GtU61hQu_nmenRQVuXGMnimZePG_i5xmiU1O6wmmTJqnpmfDrJksUFzqxiNUKMVZrEw4KD2_l9WN2M8pHaySXZ2GiaL_U1ZmfTM989S9qK2fTsrvUiXXvhoNw7AU8nHfXaR0IXcnR4_oLTiBjCzVkL6EoHx811RpDKOfd5-kkCT3DkzSWNP3OK7_KI1fizdUObS-IIjtvXmiX1qzfo63hYit8n-7hYNaoMVjtmEHQe5pUblK_VZ7VlY_qcVZ7hqQb7jNsNq8Btnk1xxWmPFut7c9iQ5wDery6fBhcJ4sGCckMeRFPkMuIwtiU28y5fqllmYE_uFIiqjsFKzh4QIFx6BLfnS5s3gMbyI3NjQBxKMVv2vC1t3-J9YQ0KudW4jFZoVOVKtvHRKmxmAttW9ReGmq8QPl8LEJ3zdAXl7fo5GMY-AybDsrb-hVzYOWUg4TKFv1p7DqeNYU0xqJIs6wQokX9Txb_mBBqX38eASRiDewlBA5_fusR_QIOskZQ1qaNl_-v9hgM40V3AKtRr0ObF5e3d_edCK93aMzWDw
link.rule.ids 230,315,730,783,787,888,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806,74073,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_8APVF_LZ-RvA1WJK2W59EZTJ1GzIU9laSJtHKTKfdXvzrvbR1OgVf21DauzT3u8vl9wM4VamJjVQ-9VVDudJNQAXjkmqM1QJjrJTKHRTu9qL2Y3A7CAd1wa2o2yq_1sRyoVZ56mrkZ9wpOToNVnY-eqNONcrtrtYSGvOw6KiqMPlavGz17vvTKosDLFEpp4aZjCPoY4OKudGFdXb28jqkTj-c-iW96V-M-btV8kfsuV6D1Ro0kovKy-swp-0GLHXrbfFN6KOzSdWZQXJDFAbAp2FmhvlHZkme2bKTnOSWYAKOrlRkVOCniSIr8AoRlvzk-SelOM4WPF63Hq7atBZLoCPMkRjFvIbHSvtMB8Y0UxmlAWIJk0YY4Y1AKxj0hkD0IVP8B2WswwYig1DpUHEEESnfhgWbW70LpMEjJUKmI3xMEEtf-EI3cWAkcWHnUntw8GWopJ7xRfLtHw9OprdxrroNCGF1PsExaGWfISCNPNip7JqMKlKNhMd-EMSce9Ccsfh0gOPBnr1js-eSD9udgsK0jO39_17HsNx-6HaSzk3vbh9W0O9B1Ux2AAvj94k-RHQxlkf1FPoEpPnQQQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9swED6xIiFeEAPGCgw8iVerlp24zRMaPyo2RoUQSH2L7NiGoM4pBF7463dO3EKHtNfEipK7i-87-_N9AIemcJnThlFm-iYs3SRUcaGpxVytMMdqbcJB4cuRPL9Nfo3TceQ_1ZFWOZsTm4naVEVYI--JoOQYNFh5z0VaxNXp8Gj6SIOCVNhpjXIan2C5n0jBOrB8fDa6up6vuATwIhtpNaxqQrM-Pm67OIYUz3sPfyY0aIlT1rQ6_Yg3_6VNvstDw3VYiwCS_Gg9_hmWrN-Alcu4Rb4J1-h40rI0SOWIwWR4NyndpHotPalK37DKSeUJFuPoVkOmNX6aqssarxDlyfue_6QRytmC2-HZzck5jcIJdIr1EqdY44jMWMZt4tyg0LJAg6SukJjtnUIrOPSMQiSiC_wfdWbTPqKE1NjUCAQUhfgCHV95-xVIX0ijUm4lPibJNFNM2QEOlBoneaFtF_Zmhspj9Nf5m6-68H1-G-M2bEYob6sXHINWZhzBqezCdmvXfNo22MhFxpIkE6ILgwWLzweEntiLd3x53_TGDieisETjO_9_rwNYwejJf_8cXezCKro9aXlle9B5fnqx3xBoPOv9GEF_AR9j1G8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+dapagliflozin+ointment+on+induced+psoriasis+in+an+experimental+model&rft.jtitle=Journal+of+medicine+and+life&rft.au=Al+bahadly%2C+Waleed+Khaled+Younis&rft.au=Bdioui%2C+Ahlem&rft.au=Al-Gazally%2C+Moaed&rft.au=Al-Saedi%2C+Haider&rft.date=2024-03-01&rft.pub=Carol+Davila+University+Press&rft.issn=1844-122X&rft.eissn=1844-3117&rft.volume=17&rft.issue=3&rft.spage=281&rft.epage=285&rft_id=info:doi/10.25122%2Fjml-2023-0084&rft.externalDBID=PMC11262602
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1844-122X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1844-122X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1844-122X&client=summon